All Stories

  1. Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease

    Article • United European Gastroenterology Journal, March 2019, SAGE Publications

    David Drobne

  2. High Infliximab Levels Offer Safe Inflammation Control in IBD

    Article • Scandinavian Journal of Gastroenterology, July 2018, Taylor & Francis

    Professor Josko Osredkar, David Drobne